Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: J Cancer Surviv. 2014 May 24;8(4):571–579. doi: 10.1007/s11764-014-0369-z

Table 1. Participant characteristics by attempting pregnancy after cancer in a cohort of female adolescent and young adult survivors (N=251).

Participant Characteristics Overall Pregnancy Attempt N=52 No Pregnancy Attempt N=199 P valuea
N (%) N (%) N (%)
Demographics
Age at Study Enrollment, years <0.01
 Mean [SD] 31.3 [5.6] 33.8 [4.7] 30.6 [5.6]
 19 to 25 47 (18.8) 3 (5.8) 44 (22.2)
 26 to 31 86 (34.4) 14 (26.9) 72 (36.4)
 32 to 37 85 (34.0) 25 (48.1) 60 (30.3)
 38 to 44 32 (12.8) 10 (19.2) 22 (11.1)
Race 0.63
 White 198 (79.2) 39 (75.0) 159 (80.3)
 Black 8 (3.2) 1 (1.9) 7 (3.5)
 Asian 13 (5.2) 3 (5.8) 10 (5.1)
 Other 31 (12.4) 9 (17.3) 22 (11.1)
Body Mass Index (kg/m2) 0.59
 < 25 146 (58.2) 27 (51.9) 119 (59.8)
 25 – 29.9 58 (23.1) 14 (26.9) 44 (22.1)
 ≥ 30 47 (18.7) 11 (21.2) 36 (18.1)
Education 0.82
 College graduate 214 (86.3) 46 (88.5) 168 (85.7)
 Did not graduate from college 34 (13.7) 6 (11.5) 28 (14.3)
Income <0.01
 ≤ $50,000 80 (31.9) 6 (11.5) 74 (37.2)
 > $50,000 120 (47.8) 37 (71.2) 83 (41.7)
 Declined to answer 51 (20.3) 9 (17.3) 42 (21.1)
Current Smoker 6 (2.4) 2 (3.9) 4 (2.0) 0.61
Comorbid Medical Conditionsb 1.00
 0 89 (35.5) 18 (34.6) 71 (35.7)
 1 or more 162 (64.5) 34 (65.4) 128 (64.3)
Reproductive Characteristics
Relationship Status <0.01
 Partnered 143 (57.0) 48 (92.3) 95 (47.7)
 Not partnered 108 (43.0) 4 (7.7) 104 (52.3)
Live Birth Before Cancer Diagnosis 41 (16.3) 12 (23.1) 29 (14.6) 0.15
Desire to Have a Baby in the Future 220 (87.6) 43 (91.5) 177 (100.0) <0.01
Cancer & Treatment Characteristics
Cancer Diagnosis 0.21
 Breast 81 (32.3) 17 (32.7) 64 (32.2)
 Lymphoma 69 (27.5) 12 (23.1) 57 (28.7)
 Blood/Leukemia 19 (7.6) 4 (7.7) 15 (7.5)
 Thyroid 14 (5.5) 7 (13.5) 7 (3.5)
 Gynecologic (cervix/uterus/ovary) 13 (5.2) 2 (3.8) 11 (5.5)
 Other 55 (21.9) 10 (19.2) 45 (22.6)
Cancer Stage 0.16
 I 53 (21.5) 11 (21.6) 42 (21.5)
 II 76 (30.9) 17 (33.3) 59 (30.3)
 III 45 (18.3) 6 (11.7) 39 (20.0)
 IV 18 (7.3) 1 (2.0) 17 (8.7)
 Unknown 54 (22.0) 16 (31.4) 38 (19.5)
Time Since Cancer Diagnosis <0.01
 Median [IQR], years 2.4 [4.0] 5.0 [7.1] 2.1 [3.3]
 ≤ 2 years 108 (43.0) 11 (21.2) 97 (48.7)
 > 2 years 143 (57.0) 41 (78.8) 102 (51.3)
Surgery 151 (60.2) 35 (67.3) 116 (58.3) 0.27
Chemotherapy 204 (81.3) 38 (73.1) 166 (83.4) 0.11
Radiation Therapy 127 (50.6) 28 (53.9) 99 (49.8) 0.64
Endocrine Therapy 48 (19.1) 11 (21.2) 37 (18.6) 0.69
Bone Marrow or Stem Cell Transplant 15 (6.0) 0 (0.0) 15 (7.5) 0.05

Note: Due to missing data, some variables do not add up to 251.

a

Fisher's exact tests were used for categorical variables, and Student's t-tests were performed for continuous variables.

b

Comorbid medical conditions included asthma/lung disease, high blood pressure, diabetes/high blood sugar, being overweight (obesity), overactive/underactive thyroid, depression/bipolar disorder, eating disorder, rheumatologic diseases, Crohn's disease/ulcerative colitis, seizures/neurologic disorders, TIA/stroke.